{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:29:09Z","timestamp":1793485749444,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jad.2026.122568","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:44:46Z","timestamp":1790783086000},"page":"122568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacological interventions for acute major depression and bipolar depression with mixed features: A systematic review and dose-related network meta-analysis across different age groups"],"prefix":"10.1016","volume":"417","author":[{"given":"Michele","family":"Fornaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balwinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Veldic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Sambataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Miola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122568_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"1994"},{"key":"10.1016\/j.jad.2026.122568_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"2013"},{"key":"10.1016\/j.jad.2026.122568_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"2022"},{"key":"10.1016\/j.jad.2026.122568_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jad.2012.07.013","article-title":"Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses","volume":"145","author":"Azorin","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.jad.2026.122568_bb0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jad.2020.07.035","article-title":"Clinical correlates of DSM-5 mixed features in bipolar disorder: a meta-analysis","volume":"276","author":"Bartoli","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4088\/JCP.v67n0108","article-title":"Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"67","author":"Bauer","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0040","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12200","article-title":"A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive treatments for bipolar depression","volume":"80","author":"Bauer","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1440-1819.2004.01234.x","article-title":"Intra-episode hypomanic symptoms during major depression and their correlates","volume":"58","author":"Benazzi","year":"2004","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.122568_bb0050","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4088\/JCP.13m08827","article-title":"Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis","volume":"76","author":"Berk","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0055","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/acer.12445","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence","volume":"38","author":"Brown","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.jad.2026.122568_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/JCP.0000000000001314","article-title":"Intravenous augmentative valproate versus Delorazepam in bipolar patients with a major depressive mixed episode and partial\/nonresponse to Oral treatment: a pilot study","volume":"41","author":"Buoli","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122568_bb0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/YIC.0000000000000580","article-title":"Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features","volume":"40","author":"Carmellini","year":"2025","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122568_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11920-020-1137-6","article-title":"Treatment of mixed features in bipolar disorder: an updated view","volume":"22","author":"Chakrabarty","year":"2020","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2026.122568_bb0075","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12132","article-title":"Effect of lurasidone on sexual function in major depressive disorder patients with subthreshold hypomanic symptoms (mixed features): results from a placebo-controlled trial","volume":"79","author":"Clayton","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamapsychiatry.2017.0624","article-title":"Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence","volume":"74","author":"Correll","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.25259\/FH_97_2025","article-title":"Mixed depression: toward a conceptual framework","volume":"3","author":"Deep","year":"2026","journal-title":"Future Health"},{"key":"10.1016\/j.jad.2026.122568_bb0090","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaac.2017.10.006","article-title":"Efficacy and safety of lurasidone in children and adolescents with bipolar I depression: a double-blind, placebo-controlled study","volume":"56","author":"DelBello","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jad.2009.10.027","article-title":"A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder","volume":"124","author":"Dodd","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JCP.0000000000001964","article-title":"Lumateperone for the treatment of major depressive disorder with mixed features or bipolar depression with mixed features: a randomized placebo-controlled trial","volume":"45","author":"Durgam","year":"2025","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122568_bb0105","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.euroneuro.2019.09.118","article-title":"P. 056 treatment of mixed states: a comparison between oral and intravenous valproate","volume":"29","author":"Federico","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122568_bb0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/ijms17020241","article-title":"Atypical antipsychotics in the treatment of acute bipolar depression with mixed features: a systematic review and exploratory meta-analysis of placebo-controlled clinical trials","volume":"17","author":"Fornaro","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2026.122568_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2018.02.085","article-title":"Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants","volume":"234","author":"Fornaro","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bdi.12612","article-title":"Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis","volume":"20","author":"Fornaro","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jad.2025.02.034","article-title":"Atypical depression and emotion dysregulation: clinical and psychopathological features","volume":"376","author":"Fornaro","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.121798","article-title":"Efficacy and safety of pharmacological interventions for the maintenance of bipolar disorder: a systematic review and dose-related network meta-analysis across different age groups","volume":"407","author":"Fornaro","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.122329","article-title":"Efficacy, acceptability, and related outcomes of pharmacological interventions for acute bipolar mania: a systematic review and dose-related network meta-analysis across different age groups","volume":"414","author":"Fornaro","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.122160","article-title":"Efficacy, acceptability, and related outcomes of pharmacological interventions for acute bipolar depression: a systematic review and dose-related network meta-analysis across different age groups","volume":"412","author":"Fornaro","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.122363","article-title":"Prevalence and outcomes of real-world bipolar depression patients underrepresented in guideline RCTs","volume":"414","author":"Fornaro","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/appi.ajp.2008.08030322","article-title":"Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression","volume":"166","author":"Frye","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0155","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291725101955","article-title":"The efficacy and safety of pharmacological treatment for major depressive episode with mixed features specifier: a systematic review and meta-analysis","volume":"55","author":"Gao","year":"2025","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.122568_bb0160","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.4088\/JCP.14com09578","article-title":"Mixed depression: a farewell to differential diagnosis?","volume":"76","author":"Goldberg","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0165","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1176\/appi.ajp.2007.05122032","article-title":"Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD","volume":"164","author":"Goldberg","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/appi.ajp.2008.08050746","article-title":"Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD","volume":"166","author":"Goldberg","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1017\/S1092852917000025","article-title":"Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension","volume":"22","author":"Goldberg","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.122568_bb0180","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jad.2020.08.048","article-title":"Major depressive disorder with mixed features and treatment response to lurasidone: a symptom network model","volume":"277","author":"Goldberg","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0185","article-title":"Mixed features in depressive and bipolar disorders: an updated systematic review","volume":"398","author":"Grasso","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0200","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.jad.2026.122568_bb0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.jad.2026.122568_bb0210","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (Updated February 2022)","author":"Higgins","year":"2022"},{"key":"10.1016\/j.jad.2026.122568_bb0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jpsychires.2010.05.016","article-title":"Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes","volume":"45","author":"Houston","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122568_bb0220","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jad.2011.12.046","article-title":"Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes","volume":"138","author":"Judd","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0225","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1176\/appi.focus.20230009","article-title":"The CANMAT and ISBD guidelines for the treatment of bipolar disorder: summary and a 2023 update of evidence","volume":"21","author":"Keramatian","year":"2023","journal-title":"Focus"},{"key":"10.1016\/j.jad.2026.122568_bb0230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4306\/pi.2009.6.2.78","article-title":"Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment","volume":"6","author":"Kim","year":"2009","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.jad.2026.122568_bb0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/acps.12140","article-title":"DSM-5 criteria for depression with mixed features: a farewell to mixed depression","volume":"129","author":"Koukopoulos","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122568_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1192\/bjp.bp.112.124404","article-title":"Mixed features of depression: why DSM-5 is wrong (and so was DSM-IV)","volume":"203","author":"Koukopoulos","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0245","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"Lam","year":"2024","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0250","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2026.122568_bb0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jad.2015.12.009","article-title":"Are manic symptoms that \u2018dip\u2019 into depression the essence of mixed features?","volume":"192","author":"Malhi","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0260","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/070674370104600902","article-title":"Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity","volume":"46","author":"Masi","year":"2001","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S1092852921000262","article-title":"Diagnosing and treating major depressive episodes that lie along the mood disorders spectrum: focus on depression with mixed features","volume":"26","author":"McElroy","year":"2021","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.122568_bb0270","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.12717","article-title":"Is obesity changing the phenotype of bipolar disorder from predominately euphoric toward mixed presentations?","volume":"20","author":"McIntyre","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0275","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","article-title":"A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0280","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1399-5618.2009.00749.x","article-title":"Asenapine versus olanzapine in acute mania: a double-blind extension study","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0285","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2009.12.028","article-title":"Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial","volume":"122","author":"McIntyre","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0290","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2014.09.026","article-title":"The prevalence and illness characteristics of DSM-5-defined \u201cmixed feature specifier\u201d in adults with major depressive disorder and bipolar disorder: results from the International Mood Disorders Collaborative Project","volume":"172","author":"McIntyre","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0295","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4088\/JCP.14m09410","article-title":"Original research lurasidone in the treatment of bipolar depression","volume":"76","author":"McIntyre","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0300","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jad.2016.12.033","article-title":"Major depressive disorder with subthreshold hypomanic (mixed) features: a real-world assessment of treatment patterns and economic burden","volume":"210","author":"McIntyre","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0305","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1017\/S1092852919001287","article-title":"Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies","volume":"25","author":"McIntyre","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.122568_bb0310","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/bdi.12941","article-title":"The effectiveness of ketamine on anxiety, irritability, and agitation: implications for treating mixed features in adults with major depressive or bipolar disorder","volume":"22","author":"McIntyre","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0315","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.122568_bb0320","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1017\/S1092852919001287","article-title":"Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies","volume":"25","author":"McIntyre","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.122568_bb0325","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/wps.20997","article-title":"The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management","volume":"21","author":"McIntyre","year":"2022","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0330","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14739","article-title":"The efficacy of lumateperone in patients with bipolar depression with mixed features","volume":"84","author":"McIntyre","year":"2023","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2026.122568_bb0335","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamapsychiatry.2026.0658","article-title":"Adjunctive antipsychotics in major depressive disorder: a systematic review and network meta-analysis","volume":"83","author":"McIntyre","year":"2026","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0340","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jpsychires.2023.06.021","article-title":"Prevalence and outcomes of rapid cycling bipolar disorder: mixed method systematic meta-review","volume":"164","author":"Miola","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122568_bb0345","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0350","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jad.2013.04.032","article-title":"Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials","volume":"150","author":"Muralidharan","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0355","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.jad.2026.122568_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.jad.2026.122568_bb0365","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/da.20191","article-title":"Retrospective analysis of psychomotor agitation, hypomanic symptoms, and suicidal ideation in unipolar depression","volume":"23","author":"Olgiati","year":"2006","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2026.122568_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103413","article-title":"Switch to mania after acute antidepressant treatment for bipolar depression: a systematic review and network meta-analysis of randomised controlled trials","volume":"87","author":"Oliva","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jad.2026.122568_bb0375","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122568_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034757","article-title":"A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state","volume":"7","author":"Patkar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2026.122568_bb0385","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.12783","article-title":"ICD-11 mixed episode: nothing new despite the evidence","volume":"21","author":"Perugi","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0390","first-page":"261","article-title":"Bipolar disorder treatment guidelines and their limits in every day clinical practice","volume":"17","author":"Perugi","year":"2011","journal-title":"Giornale Italiano di Psicopatologia"},{"key":"10.1016\/j.jad.2026.122568_bb0395","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.comppsych.2014.01.012","article-title":"Phenomenological subtypes of severe bipolar mixed states: a factor analytic study","volume":"55","author":"Perugi","year":"2014","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0400","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.4088\/JCP.14m09092","article-title":"Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study","volume":"76","author":"Perugi","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0405","first-page":"27","article-title":"Irritability in a mixed sample of patients with unipolar and bipolar II depression predicts responsiveness to lamotrigine","volume":"7","author":"Peters","year":"2018","journal-title":"Pers. Med. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0410","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122568_bb0415","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jad.2026.122568_bb0420","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1600-0447.2003.00051.x","article-title":"Frequency of manic symptoms during a depressive episode and unipolar \u2018depressive mixed state\u2019 as bipolar spectrum","volume":"107","author":"Sato","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122568_bb0425","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1016\/j.euroneuro.2019.09.319","article-title":"P. 290 early efficacy of trazodone for the treatment of depressive episodes with mixed features in patients with major depressive disorder","volume":"29","author":"Serro","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122568_bb0430","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/JCP.0000000000000764","article-title":"An open trial of iloperidone for mixed episodes in bipolar disorder","volume":"37","author":"Singh","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122568_bb0435","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/cap.2020.0018","article-title":"Lurasidone in children and adolescents with bipolar depression presenting with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial","volume":"30","author":"Singh","year":"2020","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122568_bb0440","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2174\/1570159X20666220927112625","article-title":"Sleep disturbance, irritability, and response to lurasidone treatment in children and adolescents with bipolar depression","volume":"21","author":"Singh","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2026.122568_bb0445","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(25)01140-7","article-title":"Bipolar disorder","volume":"406","author":"Singh","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.122568_bb0450","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0447.2008.01324.x","article-title":"Sub-threshold manic symptoms in recurrent major depressive disorder are a marker for poor outcome","volume":"119","author":"Smith","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122568_bb0455","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00213-014-3704-1","article-title":"Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission","volume":"232","author":"Snyder","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2026.122568_bb0460","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1017\/S1092852916000869","article-title":"Mixed features in bipolar disorder","volume":"22","author":"Sol\u00e9","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.122568_bb0465","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pnpbp.2017.05.002","article-title":"Lurasidone in post-menopausal females with major depressive disorder with mixed features: post-hoc analysis of a placebo-controlled trial","volume":"78","author":"Sramek","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0470","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1038\/s41598-021-84836-z","article-title":"A network meta-analysis of the dose\u2013response effects of lurasidone on acute schizophrenia","volume":"11","author":"Srisurapanont","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2026.122568_bb0475","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.12787","article-title":"Mixed mood states: baffled, bewildered, befuddled and bemused","volume":"21","author":"Stahl","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0480","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S1092852917000165","article-title":"Guidelines for the recognition and management of mixed depression","volume":"22","author":"Stahl","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.122568_bb0485","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122568_bb0490","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial","volume":"56","author":"Stoll","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0495","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2015.15060770","article-title":"Lurasidone for the treatment of major depressive disorder with mixed features: a randomized, double-blind, placebo-controlled study","volume":"173","author":"Suppes","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0500","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-5618.2007.00357.x","article-title":"Manic symptoms and impulsivity during bipolar depressive episodes","volume":"9","author":"Swann","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0505","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1017\/S1092852917000232","article-title":"Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis","volume":"22","author":"Swann","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.122568_bb0510","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-244X-11-101","article-title":"Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials","volume":"11","author":"Szegedi","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0515","first-page":"38","article-title":"The complexity of \u201cmixed\u201d depression: a common clinical presentation","volume":"8","author":"Targum","year":"2011","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.122568_bb0520","series-title":"R: A Language and Environment for Statistical Computing","author":"Team, R.C","year":"2023"},{"key":"10.1016\/j.jad.2026.122568_bb0525","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0530","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jad.2014.04.003","article-title":"Efficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features","volume":"164","author":"Tohen","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0535","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/acps.12911","article-title":"Characteristics of depressive and bipolar disorder patients with mixed features","volume":"138","author":"Tondo","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122568_bb0540","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1017\/S1092852917000074","article-title":"Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study","volume":"22","author":"Tsai","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.122568_bb0545","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jad.2017.09.006","article-title":"Mixed symptoms in major depressive and bipolar disorders: a systematic review","volume":"225","author":"V\u00e1zquez","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0550","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/acps.12896","article-title":"Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines","volume":"138","author":"Verdolini","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122568_bb0555","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ije\/dys222","article-title":"Evaluation of inconsistency in networks of interventions","volume":"42","author":"Veroniki","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jad.2026.122568_bb0560","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.genhosppsych.2025.12.011","article-title":"Treatment of depressive episodes with mixed features: a systematic review and meta-analysis","volume":"98","author":"Villal\u00f3n","year":"2025","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0565","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/JCP.0000000000001261","article-title":"Lurasidone efficacy in mixed depressive states: a comparison of standard rating scales to the koukopoulos mixed depression rating scale","volume":"40","author":"V\u00f6hringer","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122568_bb0570","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.4088\/JCP.08m04772gre","article-title":"Olanzapine\/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis","volume":"70","author":"Wang","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0575","doi-asserted-by":"crossref","first-page":"31","DOI":"10.64719\/pb.4449","article-title":"A randomized, double-blind, controlled clinical trial of omega-3 fatty acids and inositol as monotherapies and in combination for the treatment of pediatric bipolar spectrum disorder in children age 5\u201312","volume":"52","author":"Wozniak","year":"2022","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2026.122568_bb0580","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/bdi.70049","article-title":"The efficacy of pharmacological interventions in the treatment of major depressive disorder and bipolar depression with mixed features: a systematic review","volume":"27","author":"Xiao","year":"2025","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0585","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bdi.13135","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations","volume":"23","author":"Yatham","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122568_bb0590","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122568_bb0595","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jad.2023.07.102","article-title":"Identifying the DSM-5 mixed features specifier in depressed patients: a comparison of measures","volume":"339","author":"Zimmerman","year":"2023","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726014217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726014217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:42:26Z","timestamp":1793482946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726014217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":118,"alternative-id":["S0165032726014217"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122568","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological interventions for acute major depression and bipolar depression with mixed features: A systematic review and dose-related network meta-analysis across different age groups","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122568"}}